Kodiak Sciences Inc (KOD): Price and Financial Metrics
GET POWR RATINGS... FREE!
KOD Stock Price Chart Interactive Chart >
KOD Price/Volume Stats
| Current price | $8.08 | 52-week high | $13.40 |
| Prev. close | $7.78 | 52-week low | $4.90 |
| Day low | $7.81 | Volume | 207,700 |
| Day high | $8.48 | Avg. volume | 189,285 |
| 50-day MA | $7.53 | Dividend yield | N/A |
| 200-day MA | $8.02 | Market Cap | 422.66M |
Kodiak Sciences Inc (KOD) Company Bio
Kodiak Sciences is a clinical stage biopharma specializing in therapeutics to treat chronic retinal diseases. The company was founded in 2005 and is based in New York City, New York.
Latest KOD News From Around the Web
Below are the latest news stories about KODIAK SCIENCES INC that investors may wish to consider to help them evaluate KOD as an investment opportunity.
Kodiak Sciences to Present at the 41st Annual J.P. Morgan Healthcare ConferenceKodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2023, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time). |
Thinking Of Investing In Kodiak Sciences Inc. (NASDAQ: KOD) Stock? Read This FirstKodiak Sciences Inc. (NASDAQ:KOD) shares, rose in value on Friday, 12/30/22, with the stock price up by 4.22% to the previous day’s close as strong demand from buyers drove the stock to $7.16. Actively observing the price movement in the last trading, the stock closed the session at $6.87, falling within a range of $6.68 … Thinking Of Investing In Kodiak Sciences Inc. (NASDAQ: KOD) Stock? Read This First Read More » |
Kodiak Sciences Inc. (KOD) Up 1% Since Last Earnings Report: Can It Continue?Kodiak Sciences Inc. (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Does Kodiak Sciences Inc. (KOD) Have the Potential to Rally 87% as Wall Street Analysts Expect?The consensus price target hints at an 87.4% upside potential for Kodiak Sciences Inc. (KOD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
Kodiak Sciences to Present at the Evercore ISI 5th Annual HealthCONx ConferenceKodiak Sciences Inc. (NASDAQ: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on Tuesday, November 29, 2022, at 9:10am Pacific Time (12:10pm Eastern Time). |
KOD Price Returns
| 1-mo | N/A |
| 3-mo | 15.26% |
| 6-mo | -17.04% |
| 1-year | -35.12% |
| 3-year | -33.85% |
| 5-year | N/A |
| YTD | 12.85% |
| 2022 | -57.77% |
| 2021 | -42.29% |
| 2020 | 104.18% |
| 2019 | 913.38% |
| 2018 | N/A |
Loading social stream, please wait...